News | Neuro Imaging | April 27, 2018

Brain Scans May Help Diagnose Neurological, Psychiatric Disorders

Study shows that brain networks reliably track individuals over time

Brain Scans May Help Diagnose Neurological, Psychiatric Disorders

Brain networks from nine people were analyzed to generate the heat map above, which shows the areas that change the most (red) to the least (green), from person to person. A new study shows that individual brain networks are remarkably stable from day to day and while undertaking different tasks, suggesting that finding differences between individuals could help diagnose brain disorders or diseases. Image courtesy of Caterina Gratton.

April 27, 2018 — There are no laboratory tests to diagnose migraines, depression, bipolar disorder and many other ailments of the brain. Doctors typically gauge such illnesses based on self-reported symptoms and behavior. Now, a new study shows that a kind of brain scan called functional connectivity magnetic resonance imaging (fcMRI), which shows how brain regions interact, can reliably detect fundamental differences in how individual brains are wired. As such, the technique potentially could be used to distinguish healthy people from people with brain diseases or disorders, and provide insight into variations in cognitive ability and personality traits.

The findings were published April 18 in Neuron.

"This is a step toward realizing the clinical promise of functional connectivity MRI," said senior author Steven Petersen, Ph.D., the James S. McDonnell Professor of Cognitive Neuroscience in Neurology and a professor of neurosurgery, of biomedical engineering, of psychological and brain sciences, and of radiology. "Before we can develop diagnostic tests based on fcMRI, we need to know what it is actually measuring. We show here that it's not measuring what you're thinking, but how your brain is organized. That opens the door to an entire new field of clinical testing."

Petersen, postdoctoral researcher and first author Caterina Gratton, Ph.D., and colleagues analyzed a set of data collected by the Midnight Scan Club, a group of Washington University scientists who took turns undergoing myriad scans in an MRI machine late at night, when the demand for such machines and, consequently, the usage fees tend to be low.

The researchers analyzed data from more than 10 hours of fcMRI scans on each of nine people, collected in 10 separate one-hour sessions for each person. During the scans, each person performed tasks related to vision, memory, reading or motor skills, or rested quietly.

Functional MRI scans generate a dynamic map of the outer surface of the brain, showing changing hot spots of activity over time. To create a functional connectivity map, Gratton divided the brain's surface into 333 regions and identified areas that became active and inactive in unison. She then constructed brain network maps for each individual, showing patterns of correlation between parts of the brain.

The sheer quantity of data available on each person allowed her to analyze how much an individual's brain networks changed from day to day and with different mental tasks.

The answer? Not much.

"Brain networks captured by fcMRI are really about the individual," Gratton said. "Whether someone's watching a movie or thinking about her breakfast or moving her hands makes only a small difference. You can still identify that individual by her brain networks with a glance."

The consistency of the fcMRI scans makes them a promising diagnostic tool. Although the technique's potential to identify brain disorders and diseases was noted years ago, fcMRI-based diagnostic tests have yet to make their way into doctors' offices. Progress has been stymied by confusion over whether the scans reflect fundamental, stable features of the brain, or if they change with every passing thought.

Further, the researchers found that the technique was powerful enough to distinguish people who were extraordinarily alike. All of the scanned brains belonged to young, healthy scientists and doctors.

"We need more data before we can know what is normal variation in the population at large," Gratton said. "But the individual differences were really easy to pick up, even in a population that is really very similar. It's exciting to think that these individual differences may be related to personality, cognitive ability, or psychiatric or neurological disease. Thanks to this work, we know we have a reliable tool to study these possibilities."

For more information: www.cell.com/neuron

 

Related Content

AAPM 2019 Features More Than 40 Presentations on ViewRay's MRIdian MRI-guided Radiotherapy
News | Image Guided Radiation Therapy (IGRT) | July 16, 2019
ViewRay Inc. announced that the company's MRIdian System is the focus of more than 40 abstracts selected by the...
FDA Approves Bayer's Gadavist Contrast for Cardiac MRI in Adult Coronary Artery Disease Patients
Technology | Contrast Media | July 15, 2019
The U.S. Food and Drug Administration (FDA) has approved Gadavist injection for use in cardiac magnetic resonance...
Insightec's Exablate Neuro Approved With GE Signa Premier MRI in U.S. and Europe
News | Focused Ultrasound Therapy | July 10, 2019
GE Healthcare and Insightec announced U.S. Food and Drug Administration (FDA) approval and CE mark for Insightec’s...
Delta T1 Maps Provide Quantitative, Automated Solution to Assess Brain Tumor Burden
News | Neuro Imaging | July 05, 2019
Imaging Biometrics LLC (IB) a subsidiary of IQ-AI Ltd., is highlighting a recently published study in the American...
Medic Vision Wins Japanese PMDA Clearance for iQMR Image Reconstruction Solution
News | Magnetic Resonance Imaging (MRI) | July 05, 2019
Medic Vision Imaging Solutions announced that its 3-D iterative image reconstruction technology for shortening magnetic...
Bay Labs Announces New Echocardiography Guidance Software Data at ASE 2019 Scientific Sessions
News | Cardiovascular Ultrasound | June 20, 2019
Bay Labs announced that new data on the company’s first-of-its-kind deep learning investigational guidance software...
Third FDA Clearance Announced for Zebra-Med's AI Solution for Brain Bleed Alerts
Technology | Artificial Intelligence | June 19, 2019
Zebra Medical Vision announced it has received its third U.S. Food and Drug Administration (FDA) 510(k) clearance for...
LVivo EF Comparable to MRI, Contrast Echo in Assessing Ejection Fraction
News | Cardiovascular Ultrasound | June 19, 2019
DiA Imaging Analysis announced the presentation of two studies assessing the performance and accuracy of the company's...
New Data Demonstrates Safety Profile of GammaTile Therapy for Various Brain Tumors
News | Brachytherapy Systems | June 18, 2019
GT Medical Technologies Inc. announced the presentation of clinical data from a prospective study of GammaTile Therapy...